drugset / Trial / NCT00004266
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
Phase 3
Completed
160 enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Hennepin County Medical Center, Minneapolis · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
OBJECTIVES: I. Establish a long-term working relationship between clinical investigators and the Minnesota American Indian community. II. Compare the effectiveness of lisinopril (an angiotensin-converting enzyme inhibitor) and nifedipine (a calcium channel blocker) in preventing nephropathy and vascular disease in Minnesota American Indians with non-insulin-dependent diabetes mellitus and microalbuminuria. III. Compare the effectiveness of simvastatin (a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor) with lipid-lowering strategies recommended by the National Cholesterol Education Program in preventing nephropathy and vascular diseases in these patients.
Timeline
- Start
- 1993-08
- Primary completion
- 1999-07
- Completion
- 1999-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LISINOPRIL ANHYDROUS | Small molecule | — | — |
| Subject | Nifedipine | Other / unclassified | — | — |
| Subject | Simvastatin | Small molecule | — | — |